Pure Global

Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy and adverse effect of Janus kinase inhibitor in rheumatoid arthritis. - Trial UMIN000048381

Access comprehensive clinical trial information for UMIN000048381 through Pure Global AI's free database. This phase not specified trial is sponsored by Department of Hospital Pharmacy, Hamamatsu University School of Medicine and is currently Not yet recruiting. The study focuses on Rheumatoid arthritis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048381
Not yet recruiting
Trial Details
University Hospital Medical Information Network โ€ข UMIN000048381
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy and adverse effect of Janus kinase inhibitor in rheumatoid arthritis.

Study Focus

Rheumatoid arthritis

Observational

Sponsor & Location

Department of Hospital Pharmacy, Hamamatsu University School of Medicine

Japan

Timeline & Enrollment

N/A

Aug 01, 2022

N/A

ICD-10 Classifications

Rheumatoid arthritis, unspecified
Other rheumatoid arthritis
Other specified rheumatoid arthritis
Rheumatoid arthritis with involvement of other organs and systems
Seronegative rheumatoid arthritis

Data Source

University Hospital Medical Information Network

UMIN000048381

Non-Device Trial